Asoprisnil
- Generic Name
- Asoprisnil
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C28H35NO4
- CAS Number
- 199396-76-4
- Unique Ingredient Identifier
- 72W09924WP
- Background
Asoprisnil (J867) is a selective progesterone receptor modulator. It can be used to treat progesterone sensitive myomata.
- Indication
Investigated for use/treatment in uterine fibroids.
- Associated Conditions
- -
- Associated Therapies
- -
A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-03-04
- Lead Sponsor
- Abbott
- Target Recruit Count
- 38
- Registration Number
- NCT00156182
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 129
- Registration Number
- NCT00160459
A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 73
- Registration Number
- NCT00160420
Safety of Treatment of Uterine Fibroids With Asoprisnil
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 166
- Registration Number
- NCT00156208
A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With Endometriosis
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 130
- Registration Number
- NCT00160446
Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 523
- Registration Number
- NCT00156195
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 432
- Registration Number
- NCT00160381
Study of Asoprisnil in the Treatment of Uterine Fibroids.
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-28
- Lead Sponsor
- Abbott
- Target Recruit Count
- 149
- Registration Number
- NCT00156156
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis.
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 131
- Registration Number
- NCT00160433
Treatment of Uterine Fibroids With Asoprisnil(J867)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 475
- Registration Number
- NCT00152269
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath